Prostate-specific antigen response to withdrawal of megestrol acetate in a patient with hormone-refractory prostate cancer

被引：0
作者：
Wehbe, TW [1 ]
Stein, BS [1 ]
Akerley, WL [1 ]
机构：
[1] RHODE ISL HOSP,DEPT UROL,PROVIDENCE,RI 02902
来源：
MAYO CLINIC PROCEEDINGS | 1997年 / 72卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Clinically significant responses after withdrawal of flutamide in patients with hormone-refractory prostate cancer (HRPC) are well documented. Failure to recognize this syndrome of response results in potential morbidity due to salvage therapy, confusion in interpretation of disease state, and introduction of a possible source of error in clinical trials, In this case report, we describe a patient with HRPC whose prostate-specific antigen levels decreased substantially in response to withdrawal of megestrol acetate. Such a response should be considered when megestrol acetate is used in the treatment of HRPC.
引用
收藏
页码：932 / 934
页数：3
相关论文
共 50 条
  • [21] Induction of Tc2 cells with specificity for prostate-specific antigen from patients with hormone-refractory prostate cancer
    Supriya Perambakam
    Bao-Hua Xue
    Jeffrey A. Sosman
    David J. Peace
    Cancer Immunology, Immunotherapy, 2002, 51 : 263 - 270
  • [22] Prognostic significance of reverse transcriptase polymerase chain reaction for prostate-specific antigen in men with hormone-refractory prostate cancer
    Kantoff, PW
    Halabi, S
    Farmer, DA
    Hayes, DF
    Vogelzang, NA
    Small, EJ
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (12) : 3025 - 3028
  • [23] Are prostate-specific antigen changes valid surrogates for survival in hormone-refractory prostate cancer? A meta-analysis is needed!
    Collette, Laurence
    Buyse, Marc
    Burzykowski, Tomasz
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (35) : 5673 - 5674
  • [24] Prostate-specific antigen doubling time before onset of chemotherapy as a predictor of survival for hormone-refractory prostate cancer patients
    Oudard, S.
    Banu, E.
    Scotte, F.
    Banu, A.
    Medioni, J.
    Beuzeboc, P.
    Joly, F.
    Ferrero, J. -M.
    Goldwasser, F.
    Andrieu, J. -M.
    ANNALS OF ONCOLOGY, 2007, 18 (11) : 1828 - 1833
  • [25] Induction of Tc2 cells with specificity for prostate-specific antigen from patients with hormone-refractory prostate cancer
    Perambakam, S
    Xue, BH
    Sosman, JA
    Peace, DJ
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2002, 51 (05) : 263 - 270
  • [26] Lack of correlation between prostate-specific antigen and the presence of measurable soft tissue metastases in hormone-refractory prostate cancer
    Figg, WD
    Ammerman, K
    Patronas, N
    Steinberg, SM
    Walls, RG
    Dawson, N
    Reed, E
    Sartor, O
    CANCER INVESTIGATION, 1996, 14 (06) : 513 - 517
  • [27] A phase I trial of DNA vaccination with a plasmid expressing prostate-specific antigen in patients with hormone-refractory prostate cancer
    Pavlenko, M
    Roos, AK
    Lundqvist, A
    Palmborg, A
    Miller, AM
    Ozenci, V
    Bergman, B
    Egevad, L
    Hellström, M
    Kiessling, R
    Masucci, G
    Wersäll, P
    Nilsson, S
    Pisa, P
    BRITISH JOURNAL OF CANCER, 2004, 91 (04) : 688 - 694
  • [28] A phase I trial of DNA vaccination with a plasmid expressing prostate-specific antigen in patients with hormone-refractory prostate cancer
    M Pavlenko
    A-K Roos
    A Lundqvist
    A Palmborg
    A M Miller
    V Ozenci
    B Bergman
    L Egevad
    M Hellström
    R Kiessling
    G Masucci
    P Wersäll
    S Nilsson
    P Pisa
    British Journal of Cancer, 2004, 91 : 688 - 694
  • [29] Prostate-specific antigen levels and prognosis in patients with hormone-refractory prostate cancer treated with low-dose dexamethasone
    Morioka, M
    Kobayashi, T
    Furukawa, Y
    Jo, Y
    Shinkai, M
    Matsuki, T
    Yamamoto, T
    Tanaka, H
    UROLOGIA INTERNATIONALIS, 2002, 68 (01) : 10 - 15
  • [30] PROSTATE-SPECIFIC ANTIGEN LEVELS AND CLINICAL-RESPONSE TO LOW-DOSE DEXAMETHASONE FOR HORMONE-REFRACTORY METASTATIC PROSTATE CARCINOMA
    STORLIE, JA
    BUCKNER, JC
    WISEMAN, GA
    BURCH, PA
    HARTMANN, LC
    RICHARDSON, RL
    CANCER, 1995, 76 (01) : 96 - 100
12345